The landscape of dementia analysis has evolved significantly with the advent of refined biomarkers, like amyloid PET scans, tau imaging, and blood-dependent exams that can detect Alzheimer's pathology several years before indications arise. Although these technological developments represent extraordinary development in knowing neurodegenerative illnesses, they may have not diminished... https://omarg319ite0.wikisona.com/user